Fresenius And Aurobindo Among Fresh Velcade Challengers In US

Launches Confirmed Of Subcutaneous Bortezomib Generics As Patents Set To Expire

 
• By Dave Wallace

Multiple firms have launched bortezomib products for subcutaneous administration in the US, adding to competition on Takeda’s Velcade brand.

Launches Neon Sign Brick Wall
Launches have been confirmed for multiple Velcade rivals • Source: christitzeimaging.com / Alamy Stock Photo

More from Products

More from Generics Bulletin